High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial
Eligible for screening study DCP 001
Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.
A222301 is temporarily closed to accrual, effective Friday, May 8, 2026, at 4:30pm ET.
